Xos, Inc. (XOS) insider offloads shares under 10b5-1 plan
Rhea-AI Filing Summary
Xos, Inc. (XOS) reports an amended Form 4 for director Michael Paul Richardson, correcting prior transaction codes to reflect open‑market sales rather than dispositions to the issuer. On July 10, 13, and 14, 2026, he sold 3,119 shares of common stock on each date under a Rule 10b5-1 trading plan at weighted average prices around $2.35–$2.49 per share. On July 10, 2026, he also received a grant of 60,584 Restricted Stock Units (RSUs), which vest on the earlier of the first anniversary of the grant date or the day before Xos, Inc.'s 2027 annual meeting, subject to continued service. The amendment states no other information changes from the original Form 4.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Buyer: 51,227 shares
Net Buy
4 txns
Insider
Richardson Michael Paul
Role
Director
Sold
9,357 shs ($23K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F3, F6, F2 | 3,119 | $2.3899 | $7K |
| Sale | Common Stock F3, F5, F2 | 3,119 | $2.3473 | $7K |
| Grant/Award | Common Stock F1, F2 | 60,584 | $0.00 | $0.00 |
| Sale | Common Stock F3, F4, F2 | 3,119 | $2.4935 | $8K |
Holdings After Transaction:
Common Stock — 138,491 shares (Direct)
Footnotes (6)
- F1. The shares reported in this transaction represent Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day before the Company's 2027 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date.
- F2. Includes 60,584 unvested RSUs.
- F3. The transaction reported on this line was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025.
- F4. Represents weighted average sales price. The shares were sold at prices ranging from $2.46 to $2.59. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F5. Represents weighted average sales price. The shares were sold at prices ranging from $2.325 to $2.44. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F6. Represents weighted average sales price. The shares were sold at prices ranging from $2.35 to $2.45. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Key Figures
Shares sold July 10, 2026: 3119.0000 shares at $2.4935 per share
Shares sold July 13, 2026: 3119.0000 shares at $2.3473 per share
Shares sold July 14, 2026: 3119.0000 shares at $2.3899 per share
+2 more
5 metrics
Shares sold July 10, 2026
3119.0000 shares at $2.4935 per share
Open‑market sale of Xos, Inc. common stock under Rule 10b5-1 plan
Shares sold July 13, 2026
3119.0000 shares at $2.3473 per share
Open‑market sale of Xos, Inc. common stock under Rule 10b5-1 plan
Shares sold July 14, 2026
3119.0000 shares at $2.3899 per share
Open‑market sale of Xos, Inc. common stock under Rule 10b5-1 plan
Total shares sold
9357 shares
Sum of three open‑market sales reported in the amended Form 4
RSU grant
60584.0000 RSUs at $0.0000 per unit
Equity award of Restricted Stock Units granted July 10, 2026
Key Terms
Restricted Stock Units ("RSUs"), Rule 10b5-1 trading plan, weighted average sales price
3 terms
Restricted Stock Units ("RSUs") financial
"The shares reported in this transaction represent Restricted Stock Units ("RSUs"),"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sales price financial
"Represents weighted average sales price. The shares were sold at prices ranging"
FAQ
What insider transactions did XOS disclose for Michael Paul Richardson in this amended Form 4?
The filing reports three open‑market sales of 3,119 shares of Xos, Inc. common stock on July 10, 13, and 14, 2026, plus a grant of 60,584 RSUs on July 10, 2026, all held directly by the reporting person.
What correction does this Form 4/A make for XOS?
The amendment corrects the transaction codes for the July 10, 13, and 14, 2026 dispositions. They were previously reported as Code “D” and are now correctly designated as Code “S” for open‑market sales. The filing states no other information from the original Form 4 changes.
Were the XOS insider stock sales made under a Rule 10b5-1 plan?
Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2025, and the Rule 10b5-1 checkbox is affirmed as true.
What RSU grant did the XOS director receive on July 10, 2026?
On July 10, 2026, the director received 60,584 RSUs, each representing a contingent right to one share of Xos, Inc. common stock. The RSUs vest on the earlier of the first anniversary of the grant date or the day before the company’s 2027 annual meeting, subject to continuous service.
AI-generated analysis. How Rhea-AI works. Not financial advice.